Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Why Investing In Stocks Makes You Better At Cryptos: Part 2

Welcome to part two of this three-part series. In part one, we looked at the importance of timing and identifying high-probability assets across all markets.

Benzinga

Earnings Preview: Kraft Heinz

Kraft Heinz (NASDAQ:KHC) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Kraft Heinz will report an earnings per share (EPS) of $0.53.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Nvidia Continues To Slide But Here's Why A Bounce Is Imminent

Nvidia Corporation (NASDAQ: NVDA) was sliding almost 5% lower on Tuesday in sympathy with the S&P 500, which was trading about 1.7%.

Benzinga

Alkermes's Earnings Outlook

Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Alkermes will report an earnings per share (EPS) of $0.01.

Benzinga

Enphase Energy Whale Trades For April 26

A whale with a lot of money to spend has taken a noticeably bearish stance on Enphase Energy. Looking at options history for Enphase Energy (NASDAQ:ENPH) we detected 12 strange trades.

Benzinga

Analyzing Micron Technology Inc's Short Interest

Micron Technology Inc's (NASDAQ:MU) short percent of float has risen 7.21% since its last report. The company recently reported that it has 24.71 million shares sold short, which is 2.23% of all regular shares that are available for trading.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Looking Into Coinbase Global Inc. - Class A Common Stock's Recent Short Interest

Coinbase Global Inc. - Class A Common Stock's (NASDAQ:COIN) short percent of float has fallen 8.03% since its last report. The company recently reported that it has 6.15 million shares sold short, which is 4.24% of all regular shares that are available for trading.

Benzinga

Why Amazon Shares Are Falling

Shares of large-cap US stocks, including Amazon.com, Inc. (NASDAQ: AMZN), are trading lower amid overall market weakness as Fed rate hike outlook and economic concerns weigh on market sentiment.

Benzinga

Phio Pharmaceuticals Open enrollment in Phase 1b Trial of PH-762 for the Treatment of Advanced Melanoma

Phio Pharmaceuticals Corp. (NASDAQ: PHIO) has started enrolling patients in the Phase 1b clinical trial of PH-762 for the treatment of advanced melanoma.

Benzinga

Why Warner Bros. Discovery Shares Are Falling

Warner Bros. Discovery Inc (NASDAQ: WBD) shares are trading lower by 4.91% at $20.44 after the company reported first-quarter financial results.

Benzinga

Analysis: Will Elon Musk's Twitter Kowtow To Chinese Communist Party Influence?

When Elon Musk first notified the U.S.

Benzinga

RBB Bancorp: Dividend Insights

Thursday marks the last chance for investors to receive the next dividend payout from RBB Bancorp (NASDAQ:RBB).

Benzinga

South Plains Financial's Ex-Dividend Date Is Friday, Here's What You Need To Know

Thursday marks the last chance for investors to receive the next dividend payout from South Plains Financial (NASDAQ:SPFI).

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why This Analyst Feels Sinclair Is A 'Diamond In The Rough'

While Sinclair Broadcast Group Inc (NASDAQ: SBGI) is a diversified media company, providing high-quality content via its local television stations, sports networks and digital platforms, the market seems to be valuing it as a traditional television broadcaster, according to EF Hutton.

Benzinga

Thursday Is Your Last Chance To Buy Dorchester Minerals Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Dorchester Minerals (NASDAQ:DMLP).

Benzinga

Thursday Is Your Last Chance To Buy Sierra Bancorp Before The Dividend Payout

Thursday marks the last chance for investors to receive the next dividend payout from Sierra Bancorp (NASDAQ:BSRR).

Benzinga

5 Value Stocks In The Consumer Cyclical Sector

What is a Value Stock?

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Overview Of Value Stocks In The Technology Sector

What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

Benzinga

First Financial: Q1 Earnings Insights

First Financial (NASDAQ:THFF) reported its Q1 earnings results on Tuesday, April 26, 2022 at 10:00 AM. Here's what investors need to know about the announcement.

Benzinga

First Merchants: Q1 Earnings Insights

First Merchants (NASDAQ:FRME) reported its Q1 earnings results on Tuesday, April 26, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Benzinga

What's Going On With Microsoft Stock Today?

Microsoft Corp (NASDAQ: MSFT) shares are trading lower Tuesday ahead of the company's financial results.

Benzinga

What You Need To Know To Trade Twitter Ahead Of Thursday's Earnings

Twitter (NYSE: TWTR) is set to announce its first-quarter earnings results on Thursday and some analysts expect the microblogging platform to again incur losses on the back of its increased infrastructure and marketing spending amid tight competition.

Benzinga

Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia

The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to EDIT-301, an investigational, gene-edited medicine for the treatment of beta thalassemia from leading genome editing company, Editas Medicine, Inc. (NASDAQ: EDIT).

Benzinga

Here's How Much You Would Have Made Owning T. Rowe Price Gr Stock In The Last 20 Years

T. Rowe Price Gr (NASDAQ:TROW) has outperformed the market over the past 20 years by 3.58% on an annualized basis producing an average annual return of 10.67%. Currently, T. Rowe Price Gr has a market capitalization of $30.65 billion.

1 … 630 631 632 633

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Warner Bros Discovery

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.